|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global Cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI
|
|
2
|
Smyth EC, Nilsson M, Grabsch HI, van
Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Colombet M, Soerjomataram I,
Parkin DM, Pineros M, Znaor A and Bray F: Cancer statistics for the
year 2020: An overview. Int J Cancer. Apr 5–2021.doi:
10.1002/ijc.33588. View Article : Google Scholar
|
|
4
|
Shi AN, Zhou YB and Wang GH:
Immunotherapy: Progress and challenges of a revolutionary treatment
for gastric cancer. Zhonghua Wai Ke Za Zhi. 63:563–567. 2025.(In
Chinese). PubMed/NCBI
|
|
5
|
Chen J, Ji Y, Liu Y, Cen Z, Chen Y, Zhang
Y and Li X and Li X: Exhaled volatolomics profiling facilitates
personalized screening for gastric cancer. Cancer Lett.
590:2168812024. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheng Z, Lu J, Chen Y, Cao W and Shao Q:
The role of CD101 and Tim3 in the immune microenvironment of
gastric cancer and their potential as prognostic biomarkers. Int
Immunopharmacol. 146:1138352025. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Komekbay Z, Shirazi R, Yessultanova G,
Garifollin A, Tulyayeva A, Kereyeva N, Akhmetova S and Kaliev A:
Bibliometric analysis of tumor marker application in gastric cancer
diagnosis from 2019 to 2024. Front Med (Lausanne). 12:15478502025.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lordick F, Carneiro F, Cascinu S, Fleitas
T, Haustermans K, Piessen G, Vogel A and Smyth EC; ESMO Guidelines
Committee. Electronic address, : simpleclinicalguidelines@esmo.org:
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis,
treatment and follow-up. Ann Oncol. 33:1005–1120. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ajani JA, D'Amico TA, Bentrem DJ, Chao J,
Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Fanta P, et al:
Gastric cancer, version 2.2022, NCCN clinical practice guidelines
in oncology. J Natl Compr Canc Netw. 20:167–192. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bae SH, Kim DW, Kim MS, Shin MH, Park HC
and Lim DH: Radiotherapy for gastric mucosa-associated lymphoid
tissue lymphoma: Dosimetric comparison and risk assessment of solid
secondary cancer. Radiat Oncol J. 35:78–89. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang T, Jia L, Bian S, Chang X, Zhang Q,
Tang Q, Zhu J, Yang Z and Feng Z: TROP2 Down-regulated DSG2 to
promote gastric cancer cell invasion and migration by EGFR/AKT and
DSG2/PG/β-catenin pathways. Curr Cancer Drug Targets. 22:691–702.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rong L, Li Z, Leng X, Li H, Ma Y, Chen Y
and Song F: Salidroside induces apoptosis and protective autophagy
in human gastric cancer AGS cells through the PI3K/Akt/mTOR
pathway. Biomed Pharmacother. 122:1097262020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kang X, Xu E, Wang X, Qian L, Yang Z, Yu
H, Wang C, Ren C, Wang Y, Lu X, et al: Tenascin-c knockdown
suppresses vasculogenic mimicry of gastric cancer by inhibiting
ERK-triggered EMT. Cell Death Dis. 12:8902021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang YL, Liu P, Li D, Yang Q, Li B and
Jiang XJ: Stat-3 signaling promotes cell proliferation and
metastasis of gastric cancer through PDCD4 downregulation.
Kaohsiung J Med Sci. 36:244–249. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schlessinger J: Receptor tyrosine kinases:
Legacy of the first two decades. Cold Spring Harb Perspect Biol.
6:a0089122014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Masuda H, Zhang D, Bartholomeusz C,
Doihara H, Hortobagyi GN and Ueno NT: Role of epidermal growth
factor receptor in breast cancer. Breast Cancer Res Treat.
136:331–345. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Luo D, Liu Y, Lu Z and Huang L: Targeted
therapy and immunotherapy for gastric cancer: Rational strategies,
novel advancements, challenges, and future perspectives. Mol Med.
31:522025. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li S, Sun M, Cui Y, Guo D, Yang F, Sun Q,
Ding Y, Li M, Liu Y, Ou G, et al: Ephrin A1 functions as a ligand
of EGFR to promote EMT and metastasis in gastric cancer. EMBO J.
44:1464–1487. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ametller E, Garcia-Recio S, Pastor-Arroyo
EM, Callejo G, Carbo N, Gascon P and Almendro V: Differential
regulation of MMP7 in colon cancer cells resistant and sensitive to
oxaliplatin-induced cell death. Cancer Biol Ther. 11:4–13. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shen H, He M, Lin R, Zhan M, Xu S, Huang
X, Xu C, Chen W, Yao Y, Mohan M and Wang J: PLEK2 promotes
gallbladder cancer invasion and metastasis through EGFR/CCL2
pathway. J Exp Clin Cancer Res. 38:2472019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou Z, Zhang Z, Chen H, Bao W, Kuang X,
Zhou P, Gao Z, Li D, Xie X, Yang C, et al: SBSN drives bladder
cancer metastasis via EGFR/SRC/STAT3 signalling. Br J Cancer.
127:211–222. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mittal S, Kamath A, Joseph AM and Rajala
MS: PLCgamma1-dependent invasion and migration of cells expressing
NSCLC-associated EGFR mutants. Int J Oncol. 57:989–1000.
2020.PubMed/NCBI
|
|
23
|
Lei ZN, Teng QX, Tian Q, Chen W, Xie Y, Wu
K, Zeng Q, Zeng L, Pan Y, Chen ZS and He Y: Signaling pathways and
therapeutic interventions in gastric cancer. Signal Transduct
Target Ther. 7:3582022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cao T, Lu Y, Wang Q, Qin H, Li H, Guo H,
Ge M, Glass SE, Singh B, Zhang W, et al: A CGA/EGFR/GATA2 positive
feedback circuit confers chemoresistance in gastric cancer. J Clin
Invest. 132:e1540742022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y, Huang L, Li L, Chen L, Chen P and
Chen X: The evaluation of gastric cancer lymphovascular invasion
using CT volume perfusion. Discov Med. 36:2037–2045. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu C, Xu J, Zhang Y, Zhang R, Pan S, Chen
J, Wang Y, Zhao Q, Wang Y, Zhu W, et al: Inhibition of glutathione
peroxidase 4 suppresses gastric cancer peritoneal metastasis via
regulation of RCC2 homeostasis. Redox Biol. 80:1035192025.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Baghbanzadeh A, Rahmani S, Eslami S,
Ahmadpour Youshanlui M, Shafiee N, Shafiee A, Khalaji A and
Baradaran B: miR-146a-5p suppresses migration and downregulates
vimentin and MMP-9 expression in gastric cancer cells. Discov
Oncol. 16:10752025. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
El-Sayed SF, Mahmoud SM, Samy W, Wahid RM,
Talaat A and Seada SG: Vitamin D3 mitigates aspirin-induced gastric
injury by modulating gastrokines, E-cadherin, and inhibiting NLRP3
and NF-κB/MMP-9 signaling pathway. Tissue Cell. 93:1027242025.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wattanawongdon W, Bartpho TS and Tongtawee
T: Expression of matrix Metalloproteinase-7 predicts poor prognosis
in gastric cancer. Biomed Res Int. 2022:23009792022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yueh TC, Tsao HY, Chien WC, Tsai CW, Pei
JS, Wu MH, Chen CP, Chen CC, Wang ZH, Mong MC, et al: The
contribution of matrix Metalloproteinase-7 promoter genotypes to
hepatocellular carcinoma susceptibility. Anticancer Res.
42:5275–5282. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen L and Ke X: MMP7 as a potential
biomarker of colon cancer and its prognostic value by
bioinformatics analysis. Medicine (Baltimore). 100:e249532021.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu L, Ma GQ, Liu XD, Sun RR, Wang Q, Liu M
and Zhang PY: Correlation between GDF15, MMP7 and gastric cancer
and its prognosis. Eur Rev Med Pharmacol Sci. 21:535–541.
2017.PubMed/NCBI
|
|
33
|
Nakatani K, Yamaoka T, Ohba M, Fujita KI,
Arata S, Kusumoto S, Taki-Takemoto I, Kamei D, Iwai S, Tsurutani J,
et al: KRAS and EGFR amplifications mediate resistance to
rociletinib and osimertinib in acquired Afatinib-resistant NSCLC
harboring exon 19 deletion/T790M in EGFR. Mol Cancer Ther.
18:112–126. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gao S, Luan Y, Yu X, Wang L, Huang X, Yang
J and Liu W: TAIII suppresses the growth of T790M-mutant
non-small-cell lung cancer by targeting the EGFR/ERK signaling
pathway. Pharmaceuticals (Basel). 18:14312025. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang L, Lu YF, Wang CS, Xie YX, Zhao YQ,
Qian YC, Liu WT, Wang M and Jiang BH: HB-EGF activates the
EGFR/HIF-1α pathway to induce proliferation of Arsenic-transformed
cells and tumor growth. Front Oncol. 10:10192020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Daum O, Daumova M and Svajdler M: Comments
on the 5th edition of WHO classification of digestive system
tumors-Part 1. Gastrointestinal tract. Cesk Patol. 56:194–206.
2020.PubMed/NCBI
|
|
37
|
Qiu S, Wang Q, Jiang H and Feng L:
Immunohistochemistry staining of Eag1 and p16/Ki-67 can help
improve the management of patients with cervical intraepithelial
Neoplasia after cold knife conversion. Diagn Pathol. 19:972024.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang T, Du A, Peng Y, Yin J, Sun G, Yu Y,
Sun Z, Chang Q, Gong K, Han S, et al: DSG3 promotes bladder cancer
growth and metastasis via AKT/GSK3β/β-catenin pathway. J Transl
Med. 23:7292025. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bai T, Li P, Liu Y, Cai B, Li G, Wang W,
Yan R, Zheng X and Du S: Knockdown of miR-411-3p induces M2
macrophage polarization and promotes colorectal cancer progression
by regulation of MMP7. Eur J Histochem. 69:41782025. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hirohama D, Abedini A, Moon S, Surapaneni
A, Dillon ST, Vassalotti A, Liu H, Doke T, Martinez V, Md Dom Z, et
al: Unbiased human kidney tissue proteomics identifies matrix
metalloproteinase 7 as a Kidney disease biomarker. J Am Soc
Nephrol. 34:1279–1291. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu G, Jiang C, Li D, Wang R and Wang W:
MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in
gastric cancer. Tumour Biol. 35:9801–9806. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Morgan E, Arnold M, Camargo MC, Gini A,
Kunzmann AT, Matsuda T, Meheus F, Verhoeven RHA, Vignat J,
Laversanne M, et al: The current and future incidence and mortality
of gastric cancer in 185 countries, 2020-40: A population-based
modelling study. EClinicalMedicine. 47:1014042022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ge X, Lin F, Wu Z, Lin Y, Tang W, McKay
MJ, Sahu A, Lino-Silva LS, Tseng J and Li J: Role of ROR2 in
promoting gastric cancer metastasis by enhancing c-JUN-mediated
MMP3 transcription. Ann Transl Med. 10:11172022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu HQ, Song S, Wang JH and Zhang SL:
Expression of MMP-3 and TIMP-3 in gastric cancer tissue and its
clinical significance. Oncol Lett. 2:1319–1322. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Dong Z, Guo S, Wang Y, Zhang J, Luo H,
Zheng G, Yang D, Zhang T, Yan L, Song L, et al: USP19 Enhances
MMP2/MMP9-mediated tumorigenesis in gastric cancer. Onco Targets
Ther. 13:8495–8510. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang HL, Zhou PY, Zhang Y and Liu P:
Relationships between abnormal MMP2 expression and prognosis in
gastric cancer: A meta-analysis of cohort studies. Cancer Biother
Radiopharm. 29:166–172. 2014.PubMed/NCBI
|
|
47
|
Choi EK, Kim HD, Park EJ, Song SY, Phan
TT, Nam M, Kim M, Kim DU and Hoe KL: 8-Methoxypsoralen induces
apoptosis by upregulating p53 and inhibits metastasis by
downregulating MMP-2 and MMP-9 in human gastric cancer cells.
Biomol Ther (Seoul). 31:219–226. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li T, Cao H, Wu S, Zhong P, Ding J, Wang
J, Wang F, He Z and Huang GL: Phosphorylated ATF1 at Thr184
promotes metastasis and regulates MMP2 expression in gastric
cancer. J Transl Med. 20:1692022. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tregunna R: Serum MMP7 levels could guide
metastatic therapy for prostate cancer. Nat Rev Urol. 17:6582020.
View Article : Google Scholar
|
|
50
|
Sizemore ST, Sizemore GM, Booth CN,
Thompson CL, Silverman P, Bebek G, Abdul-Karim FW, Avril S and Keri
RA: Hypomethylation of the MMP7 promoter and increased expression
of MMP7 distinguishes the basal-like breast cancer subtype from
other triple-negative tumors. Breast Cancer Res Treat. 146:25–40.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Gao Y, Nan X, Shi X, Mu X, Liu B, Zhu H,
Yao B, Liu X, Yang T, Hu Y, et al: SREBP1 promotes the invasion of
colorectal cancer accompanied upregulation of MMP7 expression and
NF-κB pathway activation. BMC Cancer. 19:6852019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Janecka-Widla A, Majchrzyk K,
Mucha-Malecka A and Biesaga B: EGFR/PI3K/Akt/mTOR pathway in head
and neck squamous cell carcinoma patients with different HPV
status. Pol J Pathol. 72:296–314. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Lu X, An L, Fan G, Zang L, Huang W, Li J,
Liu J, Ge W, Huang Y, Xu J, et al: EGFR signaling promotes nuclear
translocation of plasma membrane protein TSPAN8 to enhance tumor
progression via STAT3-mediated transcription. Cell Res. 32:359–374.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Greenspan LJ, de Cuevas M, Le KH, Viveiros
JM and Matunis EL: Activation of the EGFR/MAPK pathway drives
transdifferentiation of quiescent niche cells to stem cells in the
Drosophila testis niche. Elife. 11:e708102022. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Liang N, Bing Z, Wang Y, Liu X, Guo C, Cao
L, Xu Y, Song Y, Gao C, Tian Z, et al: Clinical implications of
EGFR-associated MAPK/ERK pathway in multiple primary lung cancer.
Clin Transl Med. 12:e8472022. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Yu J, Fang T, Yun C, Liu X and Cai X:
Antibody-drug conjugates targeting the human epidermal growth
factor receptor family in cancers. Front Mol Biosci. 9:8478352022.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hu DD, Chen HL, Lou LM, Zhang H and Yang
GL: SKA3 promotes lung adenocarcinoma metastasis through the
EGFR-PI3K-Akt axis. Biosci Rep. 40:BSR201943352020. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Chang CH, Chen MC, Chiu TH, Li YH, Yu WC,
Liao WL, Oner M, Yu CR, Wu CC, Yang TY, et al: Arecoline promotes
migration of A549 lung cancer cells through activating the
EGFR/Src/FAK pathway. Toxins (Basel). 11:1852019. View Article : Google Scholar : PubMed/NCBI
|
